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Abstract
Keﬁran from keﬁr grains, an exopolysaccharide (EPS) produced by lactic acid bacteria (LAB), has received an increasing
interest because of its safe status. This natural biopolymer is a water-soluble glucogalactan with probed health-promoting
properties. However, its biological performance has yet to be completely recognized and properly exploited. This research
was carried out to evaluate the in vitro antioxidant and the in vitro anti-inﬂammatory properties of Keﬁran biopolymer.
Regarding antioxidant activity, the results demonstrated that the Keﬁran extract possessed the strongest reducing power and
superoxide radical scavenging, over hyaluronic acid (HA, gold standard viscosupplementation treatment). This
exopolysaccharide showed a distinct antioxidant performance in the majority of in vitro working mechanisms of
antioxidant activity comparing to HA. Moreover, Keﬁran presented an interesting capacity to scavenge nitric oxide radical
comparing to the gold standard that did not present any potency. Finally, the cytotoxic effects of Keﬁran extracts on hASCs
were also performed and demonstrated no cytotoxic response, ability to improve cellular function of hASCs. This study
demonstrated that Keﬁran represented a great scavenger for reactive oxygen and nitrogen species and showed also that it
could be an excellent candidate to promote tissue repair and regeneration.
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1 Introduction
Osteoarthritis (OA), a degenerative joint disease, is char-
acterized by cartilage degeneration and osseous overgrowth.
This disease is the most common form of arthritis, affecting
predominantly the hands, spine, knee and other weight
bearing joints, causing a negative impact on the quality of
life [1]. Approximately 250 million of people worldwide
suffer from OA, causing a substantial socioeconomic bur-
den [2]. Commonly, the clinicians recommend the use of
non-steroidal anti-inﬂammatory drugs (NSAIDs), in order
to reduce pain and improve function of the affected joints
but it is usually associated with adverse events [1, 3].
Nowadays, the pharmacologic and non-pharmacologic
interventions, or the combination of both, are depending
on the pain degree and are applied only to manage it, but
there are still no effective treatments to reverse the disease
[3]. Recently, in the OA context, it has been revealed that
the most innovative and promising approach to investigate
and treat joint disorders is the use of stem cells or auto-
logous chondrocyte implantation (ACI) [4].
In the last decade, the ﬁeld of regenerative medicine and
tissue engineering has emerged, due to the promising pos-
sibility to promote tissue repair and regeneration [5]. Fur-
thermore, regenerative biology has focused on degradable
biomaterials, to either release bioactive factors promoting
the heal response and/or provide a scaffold seeded by
therapeutic cells that can repair and regenerate tissues [6].
Due to the unique structural and compositional similarities
of natural extracellular matrix, natural biomaterials have
received an increasing interest for engineered tissue scaf-
folds. Additionally, a key advantage of using these mate-
rials is their ability to interact with cells and cellular
enzymes, and to be re-modelled and/or degraded when
space for growing tissue is needed [7, 8].
Among interesting biomaterials, the most widely used in
the biomedical ﬁeld is hyaluronic acid (HA). It is the main
component of the extracellular matrix and its structure,
molecular biology and functional properties mediate cel-
lular signaling, wound repair, morphogenesis, and matrix
organization [9]. In addition, HA is used in soft tissue
augmentation and replacement as well as in surgical diag-
nostics and procedures [10]. Therefore, HA was considered
as gold standard for viscosupplementation, since it is cur-
rently used as a commercial injectable biomaterial (e.g.
osteoarthritis treatment) [11].
Keﬁran is a microbial polysaccharide extracted from the
ﬂora of keﬁr grains; the grains are usually used as a starter
of a traditional fermented milk product, originally from
Caucasian and Eastern European regions [12]. Furthermore,
this exopolysaccharide is a water-soluble branched gluco-
galactan containing approximately equal amounts of glu-
cose and galactose [13]. This probiotic is produced by lactic
acid bacteria, mainly Lactobacillus keﬁranofaciens, and
also by yeasts. Moreover, Keﬁran has been reported to
possess several beneﬁcial on human health, which has
contributed signiﬁcantly to the rising interest of this amaz-
ing biopolymer in several countries worldwide [14].
In OA disease, human body produces various endogen-
ous systems including reactive oxygen species (ROS) such
as nitric oxide (NO) and hydrogen peroxide (H2O2). Thus,
damaged tissue remains a challenge to treat due to the
limited self-healing capacity of the tissue. This highpoints
the need to ﬁnd new treatment based on biomaterials with
unique properties to heal damaged tissue [15].
In the present research, we aim to evaluate by using
various in vitro assays the biological properties of Keﬁran
polysaccharide, particularly its antioxidant property such as
reducing power, metal chelating, hydroxyl and superoxide
radical scavenging; and its anti-inﬂammatory property
through nitric oxide scavenging in a cell-free system.
Moreover, Keﬁran’s in vitro cytotoxicity and its effect on
human adipose-derived stem cells morphology and pro-
liferation were motif of study.
2 Material and methods
2.1 Materials and reagents
Keﬁran polysaccharide was isolated from keﬁr grains, as
previously described in a previous work [16]. For cyto-
toxicity analysis, the Keﬁran samples were ﬁltrated through
a 0.22 μm ﬁlter (Millipore, Billerica, MA).
Hyaluronic acid sodium salt from Streptococcus equi
used in this research, is a bacterial hyaluronic acid (HA)
which is a natural non-sulphated high molecular weight
glycosaminoglycan. HA was provided by Sigma-Aldrich
(cat 9067-32-7, 53747).
2-Deoxyribose, ascorbic acid (Vitamin C), ethylene dia-
mine tetra acetate (EDTA), ferric chloride, ferroizine,
hydrogen peroxide, iron (II) chloride, iron (II) sulfate hep-
tahydrate, naphthylethylenediamine dichloride, nicotinamide
adenine dinucleotide-reduced (NADH), nitroblue tetra-
zolium (NBT), phenazine methosulfate (PMS), phosphoric
acid, potassium ferricyanide, quercetin, sodium hydroxide,
sodium nitroprusside (SNP), thiobarbituric acid (TBA), tri-
chloroacetic acid (TCA), sulphanilamide were purchased
from Sigma Chemical Co. Milli-Q water was used to prepare
reagents for antioxidant and anti-inﬂammatory assays.
2.2 Antioxidant activity of Keﬁran and hyaluronic
acid
Keﬁran and HA samples were prepared in different con-
centrations (1 and 0.5%, w/V). The samples were diluted in
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H20; and several assays were performed to determine their
antioxidant properties: reducing power activity, metal che-
lating activity, hydroxyl radical scavenging activity and
superoxide radical scavenging activity.
2.2.1 Reducing power activity
For reducing power assay, the procedure was followed as
described by Qi et al. and Singhal et al. [17, 18] with some
modiﬁcations. Keﬁran and HA samples were incubated with
potassium ferricyanide (2% w/V) at 50 °C for 20 min. The
reaction was ended by adding trichloroacetic acid (10% w/V)
and centrifuge at 4,700 G (10min). The obtained supernatant
was mixed with H2O2 and ferric chloride (1%w/V), and the
absorbance was acquired at 700 nm. The assay was carried
out in triplicate and ascorbic acid was used as standard.
The reducing power activity of the Keﬁran and HA
samples was expressed as Ascorbic Acid Equivalent
Reducing Capacity (AAEC).
2.2.2 Metal chelating activity
Ferrous ion chelating ability of Keﬁran and HA samples
was determined according to the method of El and Kar-
akaya [19], but modiﬁed and adapted to a microplate.
Brieﬂy, a reaction mixture, containing 154 μL of Keﬁran or
HA samples (1% w/V), iron (II) chloride (15 μL, 2 mM),
was shaken and incubated for 60 min at room temperature
(RT). Ferrozine (31 μL, 5 mM) was added and the absor-
bance of the mixture was measured at 562 nm against the
blank. The assay was carried out in triplicate and EDTA
was used as standard.
The percentage of inhibition of ferrozine-Fe2+ complex
formation was given in the following formula:
Ferrous ions chelating ability %ð Þ
¼ 1 ABSsample=ABScontrol
   100
ABSsample Absorbance in the presence of the sample.
ABScontrol Absorbance of the control solution (containing
all reagents except Keﬁran or HA).
2.2.3 Hydroxyl radical scavenging activity
Hydroxyl radical scavenging activity of Keﬁran and HA
samples was assayed by deoxyribose method [20] with major
modiﬁcations. Reaction mixture contained 0.45mL of sodium
phosphate buffer (PBS) (0.2M, pH 7.0), 0.15mL of 2-
deoxyribose solution (10mM), 0.15mL of FeSO4-EDTA
solution (10 mM FeSO4, 10 mM EDTA), 0.15mL of H2O2
solution (10mM)); and 100 μL samples were added to the
mixture. Sample solutions were completed to a ﬁnal volume
(1.5 mL) with H2O then incubated at 37 °C for 4 h. Reaction
was stopped by adding 0.75mL of TCA solution (2.8%w/V)
and 0.75 mL of TBA solution (1%w/V in 50mM NaOH
solution). Solutions were boiled for 10min and then cooled.
The absorbance was measured at 520 nm against the blank.
The assay was carried out in triplicate and results were
expressed in terms of ascorbic acid equivalent antioxidant
capacity (AAEC).
Hydroxyl radical scavenging activity (HRSA) of the extract
was also reported as % inhibition of deoxyribose degradation,
which is calculated by using the following formula:
HRSA %ð Þ ¼ 1 ABSsample=ABScontrol
   100
ABSsample Absorbance in the presence of the sample,
ABScontrol Absorbance of the control solution (containing
all reagents except Keﬁran or HA).
2.2.4 Superoxide radical scavenging activity
Superoxide scavenging of Keﬁran and HA samples was
determined by the nitroblue tetrazolium (NBT) reduction
method with major modiﬁcations [21]. Reaction mixture
consisted of 500 μL of NBT solution (312 μM NBT in
100 mM phosphate buffer), 500 μL NADH solution
(936 μM NADH in 100 mM phosphate buffer, pH 7.4) and
250 μL of samples was mixed. Reaction was started by
adding 250 μL of PMS solution to the mixture. After 5 min,
absorbance was measured at 560 nm. The assay was carried
out in triplicate and results were expressed in terms of
ascorbic acid equivalent antioxidant capacity (AAEC).
Superoxide radical scavenging activity (SRSA) of the
extract was also reported as % inhibition of superoxide
radical which is calculated by using the following formula:
SRSA %ð Þ ¼ 1 ABSsample=ABScontrol
   100
ABSsample Absorbance in the presence of the sample,
ABScontrol Absorbance of the control solution (containing
all reagents except Keﬁran or HA).
2.3 Anti-inﬂammatory activity of Keﬁran and
hyaluronic acid
The ability of Keﬁran and HA samples to scavenge nitric
oxide radical generated in a cell-free system was evaluated
according to the method previously described [22] with
some modiﬁcations. Brieﬂy, 1.5 mL of sodium nitroprus-
side (10 mM) and 1.5 mL of samples were mixed. The
samples were incubated at 37 °C for 150 min. The same
volume (3 mL) of freshly prepared Greiss reagent (N-(1-
Naphthyl)ethylenediamine) was added to the previous
mixture. All measurements were taken in triplicate.
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Absorbance of the chromaphore formed during the diazo-
tization of nitrite with sulphanilamide and subsequent
coupling with napthylethylenediamme was read at 546 nm
against the blank. The assay was carried out in triplicate and
results were expressed in terms of quercetin equivalent
antioxidant capacity (QAEC).
The amount of nitric oxide radical inhibition (NORS)
was also calculated following using the following formula:
NORS %ð Þ ¼ 1 ABSsample=ABScontrol
   100
ABSsample Absorbance in the presence of the sample.
ABScontrol Absorbance of the control solution (containing
all reagents except Keﬁran or HA).
2.4 In vitro cell culture studies of Keﬁran
2.4.1 Human adipose derived stem cells isolation
Human adipose derived stem cells (hASCs) were obtained
from human adipose tissue after liposuction procedure, at
Hospital da Prelada (Porto, Portugal), after patient’s
informed consent and under a collaboration protocol
approved by the ethical committees of both institutions. In
order to isolate the hASCs, the adipose tissue was submitted
to the action of 0.05% collagenase type II (Sigma), under
agitation for 1 h at 37 °C. Then, it was ﬁlter with a strainer
and centrifuged at 800 G for 10 min. After discarded the
supernatant, pellets were re-suspended in PBS and cen-
trifuged at 350 G for 5 min. Finally, the cell pellet was re-
suspended in Minimum Essential Media α (α-MEM,
Gibco), supplemented with 10% fetal bovine serum (FBS,
Invitrogen), and 1% antibiotic/antimycotic (Invitrogen).
Cultures were maintained at 37 °C under a humidiﬁed
atmosphere of 5% v/V CO2 in air. hASCs were selected by
plastic adherence and passage at 80% conﬂuence. hASCs in
passage 4 were used for this study.
2.4.2 Cell culture
The evaluation of cytotoxicity of Keﬁran polysaccharides
using hASCs was performed as described for L929 cells
line, following ISO 10993-12 (2012) guidelines.
First, hASCs were seeded in each well of a 96-well plate at
a density of 3000 cells/cm2. Then, in accordance with ISO
10993-12, Keﬁran sample was prepared (4%w/V) in 0.9%w/
V of NaCl. On the next day, the culture medium was replaced
for the previous solution diluted in culture medium at ﬁnal
concentration of 1% v/V. Additionally, a negative control
(Ctrl-) was prepared composed of culture medium and a
positive control (Ctrl+) composed of Triton X-100 (Sigma-
Aldrich) at a concentration of 1% v/V in culture medium.
Cultures were maintained at 37 °C under a humidiﬁed
atmosphere of 5% v/V CO2 in air. Finally, at 24, 48 and 72 h
of culture, Keﬁran’s cytotoxicity, cell proliferation and mor-
phology were analyzed as described below.
2.4.3 Keﬁran’s cytotoxicity
Cytotoxicity was assessed using the CellTiter 96® AQueous
One Solution Cell Proliferation Assay (MTS, Promega). At
each time point, 24, 48 and 72 h cells were incubated with
20% v/V of MTS in culture medium without phenol red
(Sigma) for 3 h at 37 °C. The supernatant was then trans-
ferred to a new 96-well plate and absorbance measurements
were carried out using a microplate reader (Biotek Synergy
HT) at 490 nm.
2.4.4 Cell morphology
Cell morphology was studied through F-actin staining. For
that, cells were washed with phosphate buffer saline (PBS,
Sigma-Aldrich), ﬁxed with 10% Neutral Buffered Formalin
(ThermoFisher Scientiﬁc) for 15 min and permeabilized for
5 min with 0.1% v/V Triton X-100 (Sigma-Aldrich) in PBS.
Afterwards, samples were incubated for 30 min in 1%w/V
BSA (Sigma-Aldrich) in PBS to block unspeciﬁc binding. F-
actin ﬁlaments were stained with
Phalloidin–Tetramethylrhodamine B isothiocyanate (Sigma-
Aldrich, 1:40) and nuclei were counterstained with 1:5000
of the stock of 4,6-Diamidino-2-phenyindole, dilactate
solution (DAPI, 1 mg/mL, Biotium). Samples were analyzed
by ﬂuorescence inverted microscope (Zeiss Axio observer).
2.5 Statistical analysis
All quantitative experiments were run in triplicate and
results were expressed as mean values ± standard devia-
tions. For in vitro cell culture studies, statistical analyses
were performed using GraphPad Prism 6.0 software. The
non-parametric Mann–Whitney test was used to compare
two groups, whereas the comparison between more than
two groups was performed using the Kruskal–Wallis test,
followed by Dunn’s comparison test. The critical level of
statistical signiﬁcance chosen was p < 0.05.
3 Results
3.1 Antioxidant activity of Keﬁran and HA samples
3.1.1 Reducing power activity
In this research, the reducing power assay of Keﬁran and
HA polysaccharides was performed and the results were
shown in Table 1.
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Keﬁran showed an interesting reducing power activity,
almost 8.5 μg AAEC per mL of Keﬁran solution (1% wV).
Contrary to Keﬁran polysaccharide, hyaluronic acid did not
show any reducing power performance. In fact, Keﬁran
showed to be a good electron donor that can terminate the
radical chain reactions by converting free radicals to more
stable products.
3.1.2 Metal chelating activity
The metal chelating activity of Keﬁran and hyaluronic acid
at different concentrations (1 and 0.5% w/V) were per-
formed in our study. The results of the ferrous ion-chelating
effect of Keﬁran and HA polysaccharides were shown in
Table 2.
Our research demonstrated that the ferrous ion-chelating
performance of Keﬁran and HA samples were low, com-
pared to EDTA. In fact, these polysaccharides demonstrated
almost 27 and 28.5%, respectively, of Fe2+ ion chelating
ability at 10 mg/mL where the standard EDTA showed
91.1% at a lower concentration (1.5 mg/mL).
3.1.3 Hydroxyl radical scavenging activity
In our research, the scavenging activities on hydroxyl
radical of Keﬁran and hyaluronic acid were determined and
represented in Fig. 1a.
Keﬁran and HA samples showed almost the same
capacity to scavenge hydroxyl radicals (73.7 and 74.4%,
respectively) at 1% (w/V). At the two concentrations tested,
the scavenging activity of both polysaccharides presented
an identical increasing tendency. These results clearly
showed that Keﬁran and HA polysaccharides have an
equally strong scavenging action on O2
–· radicals.
3.1.4 Superoxide radical scavenging activity
Figure 1b presented the superoxide scavenging capacity of
Keﬁran and HA samples. Keﬁran polysaccharide presented
a slightly higher capacity to scavenge superoxide radicals
than HA (14 and 11%, respectively) at the same con-
centration (0.5% w/V). In the present study, as shown in
Fig. 1b, the scavenging effects of both polysaccharides were
generally enhanced by the increase in concentrations that
enriched to 26% for Keﬁran and 19% for HA at 1% w/V.
3.2 Anti-inﬂammatory activity of Keﬁran and
hyaluronic acid
Since the presence of an excess of NO radicals in the system
is deleterious to human health, it is important to evaluate
in vitro the nitric oxide scavenging activity of Keﬁran. In
this sense, our research aim to evaluate the use of Keﬁran
polysaccharide as biomaterial for tissue engineering and
medicine regenerative applications.
To do so, Keﬁran and hyaluronic Acid samples were
prepared in different concentrations (1 and 0.5% w/V) and
then diluted in H2O. The obtained results on nitric oxide
scavenging activity were presented in Table 3.
The results conﬁrmed the interesting capacity of Keﬁran
to scavenge nitric oxide, especially when compared to HA
Table 1 Reducing power activity of Keﬁran and HA samples
Samples (% w/V) Ascorbic acid equivalent capacity (AAEC) (μg/
mL of sample solution)
Keﬁran 1% 8.47 ± 0.04
Keﬁran 0.5% 4.44 ± 0.05
HA 1% –
HA 0.5% –
Table 2 Metal chelating activity of Keﬁran and HA samples
Samples (% w/V) Iron chelating capacity (%)
Keﬁran 1% 26.66 ± 0.05
Keﬁran 0.5% 20.19 ± 0.02
HA 1% 28.5 ± 0.04
HA 0.5% 24.05 ± 0.05
0
50
100
150
200
250
300
350
400
Kefiran 1% Kefiran 0.5% HA 1% HA 0.5%
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Samples (% w/V)
B
A
Fig. 1 Hydroxyl a and superoxide b radical scavenging activity of
Keﬁran and HA samples. Inhibition percentage of radical production
(black bars) and ascorbic acid equivalent reducing capacity, AAEC
(white bars) of Keﬁran and HA samples at different concentrations (1
and 0.5%w/V)
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that did not present any potency in this assay. In fact, the
nitric oxide scavenging activity of Keﬁran polysaccharide
was about 41% at 10 mg/mL; whereas, as expected, the
standard quercetin showed a more pronounced capacity
(78%) at a lower concentration (1 mg/mL).
3.3 Analysis of cytotoxicity of Keﬁran using human
primary cells
In this research, the cytotoxicity of Keﬁran extract was
assessed using primary cells (human Adipose-derived
Stem Cells, hASCs) (Fig. 2). The metabolic activity of
cells during 72 h was performed using MTS assay (Fig.
2a) and the cell morphology was also investigated by
means of performing the F-actin staining, along 72 h of
culture (Fig. 2b). In basal culture conditions, hASCs
presented a signiﬁcant increase of metabolic activity
along the time. These observations were also corroborated
by F-actin staining as illustrated in Fig. 1b. It is interesting
to observe that Keﬁran extract presented higher metabolic
activity than Ctrl-.
Indeed, comparing to the negative control, Keﬁran
polysaccharide demonstrated higher metabolic activity
along time (24, 48 and 72 h). Moreover, it is important to
point out that images of F-actin and DAPI staining showed
no deleterious effect on cell’s morphology and demon-
strated also an increase on cell proliferation along the
incubation time.
4 Discussion
Free radicals are atoms or groups of atoms which attack
important macromolecules leading to cell damage
and homeostatic disruption, causing several inﬂammatory
and degenerative processes such as cancer, neurodegen-
erative disorders and arthritis, among others [23].
Therefore, intervention of antioxidant molecules is neces-
sary in living cells to interact with these free radicals and
terminate the chain reaction in order to prevent cell damage
[24].
4.1 Antioxidant activity of Keﬁran and hyaluronic
acid
Regarding the reducing power activity assay, it consists of
measuring the electron-donating capacity of an antioxidant
compound using the potassium ferricyanide reduction
approach. Compounds, having reducing potential, convert
the Fe3+/Ferricyanide complex to the ferrous from which
acts as an important indicator of its antioxidant performance
[25]. In our research, the reducing power of Keﬁran poly-
saccharide, showed a concentration-dependent response.
Same statement was also observed in other polysaccharides
from bacteria such as Pseudomanas PF-6 [23] and Peani-
bacillus mucilaginosus TKU032 [26]. In fact, it has been
showed that the exopolysaccharides extracted from these
bacteria demonstrated a signiﬁcant reducing power activity
that increase with concentration. The antioxidant activity of
a polysaccharide depends mainly on its structural char-
acteristics, including molecular weight, chain conformation,
monosaccharide content, and conﬁguration of the glycosidic
linkage, among others, and is probably not due to one single
factor but to the interaction of several factors [26].
Furthermore, one of the mechanisms of antioxidant
defence is chelation of transition metals, thus preventing
catalysis of Fenton reactions and hydroperoxide decom-
position. The principal strategy to avoid reactive oxygen
species generation that is related with redox active metal
catalysis implicates chelating of the metal ions [25, 27]. It is
important to highlight that generally, the structure of poly-
saccharide compounds containing more than one of the
following functional groups as –C=O, -COOH, -O-, -OH,
-PO3H2, -NR2, -S- and –SH contribute to its metal chelating
performance. Concerning the Keﬁran polysaccharide
extracted from keﬁr grains, it has been showed that its
chemical structure containing only O- and -OH functional
groups [13, 16]. Moreover, the absence of uronic acid and
sulfate groups in Keﬁran and HA polysaccharides could be
an explanation to the low chelating ability of these poly-
saccharides [28].
The hydroxyl radical (OH) is the most reactive of the
oxygen species and causes signiﬁcant damage to adjacent
biomolecules [29]. Several polysaccharides can release
hydrogen proton to react with hydroxyl radicals, causing
decreased of the rate of hydroxyl radical attack on deox-
yribose [30]. A research of Guo and co-workers [31]
reported that the inhibition percentage of hydroxyl radical
production in exopolysaccharide extracted from Edward-
siella tarda was slightly higher (90% at 8 mg/mL) than
Keﬁran exopolysaccharide extracted in our study (74% at
10 mg/mL) and hyaluronic acid (74.4% at 10 mg/mL). It is
important to highlight that Keﬁran and HA polysaccharides
showed almost similar hydroxyl radical scavenging and
Table 3 Nitric oxide radical scavenging capacity of Keﬁran and HA
samples
Samples (%
w/V)
Inhibition percentage of nitric
oxide radical production (%)
QAEC (mg/mL of
sample solution)
Keﬁran 1% 40.91 ± 0.04 0.16 ± 0.02
Keﬁran 0.5% 3.92 ± 0.03 –
HA 1% – –
HA 0.5% – –
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metal chelating activities. This is in agreement with earlier
study that reported a similar correlation investigating an
extracellular polysaccharide extracted from Nostoc com-
mune [32].
Not to mention that superoxide dismutase (SOD), is one
of the most important antioxidative enzymes, catalyzes the
dismutation of the superoxide anion (O2
–) into hydrogen
peroxide (H2O2) and molecular oxygen. The effect of
polysaccharide samples on superoxide generated in a PMS/
NADH nonenzymic system was measured spectro-
photometrically [33, 34]. In a previous research that
studied exopolysaccharide isolated from Pseudomonas PF-6
[23], it has been showed a stronger superoxide radical
scavenging activity (80%) at a much lower concentration
(0.25 mg/mL) comparing to Keﬁran extracted in our
research (26%) at 10 mg/mL. The difference between the 2
A
bs
 4
90
 n
m
 
Fig. 2 Keﬁran cytotoxicity using
human primary cells. a Keﬁran
extract’s cytotoxicity on hASCs
cultured during 72 h assessed by
MTS assay. (*) denotes
statistical signiﬁcant differences
(p < 0.05) along the time of
culture. b Cell morphology
assessed by F-actin staining
(cytoskeleton, red) and
counterstained with DAPI
staining (nuclei, blue), during
72 h of culture (scale bar: 50 µm)
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exopolysaccharides could be explained by the fact that the
molecular weight of the polysaccharides extracted from
these Pseudomonas was higher (8.83 × 105 Da) [23] than
Keﬁran in this study (1.52 × 105 Da). In fact, polysaccharide
molecular weight is one of the most important structural
factor in antioxidant performance [31].
Moreover, as mentioned in the literature, the content of
protein and pigment in polysaccharide extracts appeared to
contribute to a direct scavenging effect on superoxide and
hydroxyl radicals which may explain the difference in
radical scavenging capacity observed in different poly-
saccharide extracts [23, 31]. It is important to highlight that
many other factors, such as molecular weight, variation of
monosaccharide composition, structure conﬁguration and
other chemical components in polysaccharide fractions,
were also supposed to play an important role in their anti-
oxidant activities [28].
In this research, it has been showed that Keﬁran biopo-
lymer have a high antioxidant potential. In fact, this exo-
polysaccharide showed a distinct antioxidant activity in the
majority of in vitro working mechanisms of antioxidant
activity comparing to hyaluronic acid (gold standard in
viscosupplementation). There are few references in the lit-
erature regarding the antioxidant performance of Keﬁran
exopolysaccharide isolated from keﬁr grains, which high-
lights the importance of the results obtained in our research.
4.2 Anti-inﬂammatory activity of Keﬁran and
hyaluronic acid
Nitric oxide (NO) is a signiﬁcant mediator of various
physiologic and pathologic processes. NO, a water- and
lipid-soluble gas, is perfectly appropriate as a powerful
inﬂammatory mediator due to its strong reactivity with
oxygen, superoxide, and iron-containing compounds [23].
The NO does not interact directly with the bioorganic
macromolecules, like proteins and DNA. Although, in
aerobic conditions, NO is an unstable molecule that inter-
feres with oxygen to produce stable products such as NO2,
N2O4 and N3O4, among others [24].
The demonstration of Keﬁran anti-inﬂammatory perfor-
mance (as compared to a gold standard biomaterial—HA) is
highly relevant as it may induce cell protection in contexts
of high oxidative stress. In fact, Keﬁran polysaccharide
exhibited excellent NO scavenging activity, leading to the
reduction of the nitrite concentration in the medium.
Oxidative stress is a promoter of cell death and causes
severe interferences in the normal physiological functioning
of the host. Thus, the results obtained in our research justify
a potential advantage of Keﬁran biopolymer as a bioactive
molecule for cell protection in oxidative stress environ-
ments, including inﬂammation contexts. Our research
demonstrated that Keﬁran represented a great scavenger for
reactive oxygen species and reactive nitrogen species,
which is greatly relevant taking into account its potential
pharmaceutical application. It is important to highlight that
the potential contribution of any biomaterial to oxidative
stress is very relevant when assessing biocompatibility of
new biomaterials candidates. In fact, the demonstration of
antioxidant and anti-inﬂammatory properties is important in
order to prove that the biomaterial candidate does not
contribute to any pro-oxidative stress.
4.3 Analysis of cytotoxicity of Keﬁran using human
primary cells
It is important to point out that the incorporation of Keﬁran
extract in the medium culture improved the viability and the
metabolic activity of hASCs. This is especially promising as
these stem cells present the ability to differentiate into
several lineages and display a tremendous potential for
tissue engineering and regenerative medicine applications
[35, 36].
The L929 cell line is widely used as model for in vitro
evaluation of the cytotoxicity activity of an extract. How-
ever, due to immortalization, the response of L929 cells
might diverge from primary cells such as hASCs. In this
sense, no cytotoxicity of Keﬁran polysaccharide with
hASCs presented an important proof of the possibility of
Keﬁran use in cartilage and/or bone regeneration. There-
fore, further assays on cell-loaded Keﬁran scaffolds in
in vivo model will be invaluable for the development of this
polysaccharide as suitable biomaterial for cartilage and/or
bone tissue regeneration.
5 Conclusions
The present research showed that Keﬁran polysaccharide
extracted from keﬁr grains possesses a wide-ranging bene-
ﬁcial therapeutic effects and health-promoting properties. In
fact, Keﬁran demonstrated a potential antioxidant perfor-
mance against reactive oxygen species, highlighting Keﬁran
potential in providing cell protection in environments of
oxidative stress. Moreover, this polysaccharide con-
siderably induced NO, which could suggest that this bio-
polymer is an interesting immunostimulator. The results
obtained substantiate our knowledge on the biological per-
formance such as antioxidant and anti-inﬂammatory prop-
erties, and cytotoxicity effect of Keﬁran polysaccharide; and
encourage the use of this promising biopolymer as an
alternative or adjunct treatment to promote tissue repair and
regeneration while reducing the inﬂammation in OA
context.
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